Dyadic International, Inc., based in Jupiter, Florida, with operations in the United States, Poland and The Netherlands, is a global biotechnology company that uses its patented and proprietary technologies (the “Dyadic Platform Technology”) to conduct research and development activities for the discovery, development, and manufacture of products and enabling solutions to the bioenergy, industrial enzyme and pharmaceutical industries. These enabling solutions primarily include:

• Novel, cost efficient production strains, enzyme mixes and related processes and manufacturing technologies currently in the research and development stage for producing abundant low cost fermentable sugars from agricultural residues and energy crops which may be used in the manufacturing of cellulosic ethanol, butanol, chemicals, chemical intermediates, polymers and other biomolecules of commercial interest, obviating the need for petroleum as a feedstock, and refer to our activities in this market as our BioEnergy Business;
• Enzymes and other biological products for a variety of industrial and commercial applications. We currently sell more than 55 liquid and dry enzyme products to more then 200 industrial customers in approximately 50 countries, and refer to our activities in this market as our Enzyme Business; and
• Low-cost production hosts for therapeutic protein production for the biopharmaceutical industry, and refer to our activities in this market as our BioPharma Business.

As more and more industries come to appreciate the financial, process efficiency, environmental and other advantages of applying biological solutions such as enzymes to their manufacturing processes in lieu of chemicals and other legacy technologies, we expect a variety of new market opportunities to emerge for which we anticipate we will be able to apply the Dyadic Platform Technology.